中國綠寶(06183.HK)擬收購高科技互聯網企業佰納生態若干股本權益
格隆匯 8 月 7日丨中國綠寶(06183.HK)宣佈,於2020年8月5日,公司與賣方珠海莊氏文化產業發展有限公司就公司(或其全資附屬公司)可能向賣方收購目標公司廣東佰納生態科技有限公司若干股本權益的共同意願訂立諒解備忘錄。
據悉,目標公司是一家集軟件與硬件開發、平台運營的高科技互聯網企業。於2016年8月在廣東省 •橫琴新區註冊,實繳資本超過人民幣2,500萬元。於公告日期,賣方於目標公司中擁有100%股權。
在目前疫情影響下,出口貿易可能面臨更多未知性,本公司更需要通過新零售電商項目對其系列產品鏈打開內銷渠道。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.